[ Price : $8.95]
FDA warns Medical Center Pharmacy, Cleveland, TN about insanitary conditions and other violations in its compounding of sterile dr...[ Price : $8.95]
Sen. Bernie Sanders and Rep. Peter DeFazio introduce a rule to require federal agencies to negotiate fair pricing agreements with ...[ Price : $8.95]
Four stakeholder groups praise FDA efforts in publishing the Biosimilar User Fee Agreement Statement of Work before the 10/1 antic...[ Price : $8.95]
FDA grants Bristol-Myers Squibb accelerated approval for Opdivo (nivolumab) for treating certain patients 12 years and older with ...[ Price : $8.95]
FDA approves Celgenes Idhifa (enasidenib) for treating adult patients with relapsed or refractory acute myeloid leukemia who have ...[ Price : $8.95]
FDA Webview editor Jim Dickinson analyzes a Washington Post article on the Essure contraceptive device and sees an ingrained patte...[ Price : $8.95]
FDA grants AstraZeneca and MedImmune a breakthrough therapy designation for Imfinzi (durvalumab) for treating patients with locall...[ Price : $8.95]
Amgen files a supplemental BLA for Prolia (denosumab) for treating patients with glucocorticoid-induced osteoporosis.